Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for skin toxicity in mCRC
NCT03448731Phase 2Completed
- Sponsor
- Fundación CRIS contra el Cáncer
- Start
- May 2018
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Skin Toxicity, sponsored by Fundación CRIS contra el Cáncer. Started May 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
Skin Toxicity
Beyond the preview
Go deeper on NCT03448731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03448731.